Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare neurological disorder that affects the nervous system. In this video , Jeffrey Allen, MD, and Todd Levine, MD, discuss common signs and symptoms of CIDP, diagnosis, and first-line treatments.
Disclosure: The faculty received modest honoraria from the Custom Programs division of Frontline Medical Communications for their time participating in this roundtable. The faculty was solely responsible for the content presented.
This video roundtable was produced by the Custom Programs division of Frontline Medical Communications.
Dr. Allen is a consultant and has received clinical trial support from CSL Behring, Biotest Pharmaceuticals Corporation, and Grifols USA, LLC.
Dr. Levine has a financial interest in Corinthian Reference Labs, and is a paid consultant for Grifols USA, LLC and NuFACTOR Specialty Pharmacy. He has an ongoing relationship with Alnylam Pharmaceuticals, Inc., Grifols USA, LLC, Shire, and Mallinckrodt Pharmaceuticals.